FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 117 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $51,547,086 | +34.5% | 11,609,704 | 0.0% | 1.02% | +40.4% |
Q2 2023 | $38,312,023 | +15.8% | 11,609,704 | 0.0% | 0.72% | -3.5% |
Q1 2023 | $33,087,656 | -52.2% | 11,609,704 | +22.1% | 0.75% | -46.7% |
Q4 2022 | $69,203,134 | +22.2% | 9,505,925 | +35.8% | 1.40% | +16.2% |
Q3 2022 | $56,630,000 | – | 7,000,000 | – | 1.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 3,962,202 | $93,706,000 | 25.43% |
TRV GP IV, LLC | 2,343,154 | $55,416,000 | 20.30% |
COWEN AND COMPANY, LLC | 3,453,371 | $81,672,000 | 7.86% |
Logos Global Management LP | 1,000,000 | $23,650,000 | 3.07% |
ACUTA CAPITAL PARTNERS, LLC | 200,000 | $4,730,000 | 2.21% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,613,412 | $61,807,000 | 1.89% |
RTW INVESTMENTS, LP | 3,611,194 | $85,405,000 | 1.77% |
Monashee Investment Management LLC | 236,991 | $5,600,000 | 1.62% |
Paradigm Biocapital Advisors LP | 212,961 | $5,037,000 | 1.33% |
Parkman Healthcare Partners LLC | 164,453 | $3,889,000 | 1.14% |